RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 84 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q4 2014. The put-call ratio across all filers is 2.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $345,000 | +66.7% | 38,504 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $207,000 | +31.0% | 38,504 | +12.0% | 0.00% | – |
| Q1 2016 | $158,000 | -11.7% | 34,367 | 0.0% | 0.00% | – |
| Q4 2015 | $179,000 | -13.9% | 34,367 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $208,000 | -69.2% | 34,367 | -19.6% | 0.00% | -50.0% |
| Q2 2015 | $675,000 | +45.2% | 42,769 | 0.0% | 0.00% | +100.0% |
| Q1 2015 | $465,000 | +3.3% | 42,769 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $450,000 | +9.8% | 42,769 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $410,000 | -25.5% | 42,769 | -10.2% | 0.00% | 0.0% |
| Q2 2014 | $550,000 | +15.5% | 47,609 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $476,000 | -23.2% | 47,609 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $620,000 | -12.8% | 47,609 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $711,000 | +59.8% | 47,609 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $445,000 | – | 47,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |